Correlation Between Oryzon Genomics and Labiana Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oryzon Genomics and Labiana Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oryzon Genomics and Labiana Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oryzon Genomics SA and Labiana Health SA, you can compare the effects of market volatilities on Oryzon Genomics and Labiana Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oryzon Genomics with a short position of Labiana Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oryzon Genomics and Labiana Health.

Diversification Opportunities for Oryzon Genomics and Labiana Health

0.82
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Oryzon and Labiana is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Oryzon Genomics SA and Labiana Health SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Labiana Health SA and Oryzon Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oryzon Genomics SA are associated (or correlated) with Labiana Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Labiana Health SA has no effect on the direction of Oryzon Genomics i.e., Oryzon Genomics and Labiana Health go up and down completely randomly.

Pair Corralation between Oryzon Genomics and Labiana Health

Assuming the 90 days trading horizon Oryzon Genomics SA is expected to generate 0.53 times more return on investment than Labiana Health. However, Oryzon Genomics SA is 1.9 times less risky than Labiana Health. It trades about -0.14 of its potential returns per unit of risk. Labiana Health SA is currently generating about -0.08 per unit of risk. If you would invest  165.00  in Oryzon Genomics SA on September 1, 2024 and sell it today you would lose (11.00) from holding Oryzon Genomics SA or give up 6.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy95.65%
ValuesDaily Returns

Oryzon Genomics SA  vs.  Labiana Health SA

 Performance 
       Timeline  
Oryzon Genomics SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oryzon Genomics SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Labiana Health SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Labiana Health SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental drivers remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Oryzon Genomics and Labiana Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oryzon Genomics and Labiana Health

The main advantage of trading using opposite Oryzon Genomics and Labiana Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oryzon Genomics position performs unexpectedly, Labiana Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Labiana Health will offset losses from the drop in Labiana Health's long position.
The idea behind Oryzon Genomics SA and Labiana Health SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Insider Screener
Find insiders across different sectors to evaluate their impact on performance